Added to YB: 2025-04-23
Pitch date: 2025-03-06
LFCR [bullish]
Lifecore Biomedical, Inc.
+2.59%
current return
Author Info
No bio for this author
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
Market Cap
$237.1M
Pitch Price
$6.18
Price Target
N/A
Dividend
N/A
Sector
Life Sciences Tools and Services
Category
value
Lifecore Biomedical, Inc. - $LFCR
LFCR: CDMO w/ 80% rev, 20% in hyaluronic acid sales. Undervalued due to past misstatements, leverage (>5x EBITDA), failed sale process. 5-head isolator filler at 20% utilization; mgmt expects 40-60% rev growth in 36-48 months. $300M capacity potential in 10% growth injectable market. M&A likely given CDMO deals at 20-32x EBITDA. Projected 13x EV/EBITDA by 2028.
Read full article (6 min)